Related Experiment Videos
Seventeen-year survival in multiple myeloma
1Department of Medicine, University of California, Davis School of Medicine.
American Journal of Hematology
|March 1, 1989
Summary
This case study details a multiple myeloma patient with a 17-year survival and 13 years in remission. Unhealed lytic bone lesions persist despite long-term remission.
Area of Science:
- Hematology
- Oncology
Background:
- Multiple myeloma is a hematologic malignancy.
- Long-term remission is a treatment goal.
Purpose of the Study:
- To report a rare case of prolonged remission in multiple myeloma.
- To highlight the persistence of bone lesions despite remission.
Main Methods:
- Case report.
- Review of patient's medical history.
Main Results:
- The patient survived 17 years post-diagnosis.
- Continuous complete remission was achieved for 13 years after a relapse.
- Multiple lytic bone lesions remained unhealed.
Conclusions:
- Prolonged remission is achievable in multiple myeloma.
- Lytic bone lesions may persist even after achieving complete remission.
- Further research into managing bone disease in long-term survivors is warranted.